Comment on: A Soaring Price, a Silent Fight: Thioguanine Portends New Access Barriers to Life-Saving Treatments for Children With Cancer: The Ugly Duck or The Chicken with the Golden Eggs: The Crisis in Thioguanine Accessibility.

Autor: Bayoumy AB; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam, The Netherlands., Mulder CJJ; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam, The Netherlands., De Boer NKH; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam, The Netherlands., Derijks LJJ; Department of Clinical Pharmacy and Clinical Pharmacology, Máxima Medical Center, Veldhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center, Maastricht, The Netherlands., Yang JJ; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Schmiegelow K; Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Jazyk: angličtina
Zdroj: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Nov 30, pp. e31464. Date of Electronic Publication: 2024 Nov 30.
DOI: 10.1002/pbc.31464
Databáze: MEDLINE